Workflow
Jiangyin Huaxin Precision Technology Corporation(603370)
icon
Search documents
3股盈利翻倍!三季报业绩抢先看
Sou Hu Cai Jing· 2025-10-06 01:47
Core Insights - As of the end of September, 26 A-share listed companies have released their earnings forecasts for the third quarter of 2025, with 10 from the Beijing Stock Exchange not providing specific profit figures [1] - Among the companies, 11 provided clear predictions for their net profit ranges for the first three quarters, while 5 were newly listed companies [1] Group 1: Company Performance - Luxshare Precision's net profit for the first three quarters exceeded 10 billion yuan, reaching 11.117 billion yuan [1] - Other companies with net profits exceeding 300 million yuan include Changchuan Technology (850 million yuan), Dalian Heavy Industry (491 million yuan), Wanhua Chemical (380 million yuan), YouSheng Co. (354 million yuan), and Zhongtai Co. (340 million yuan) [1][2] - Significant net profit growth was observed in companies such as Yinglian Co. (1602.05% increase), Brother Technology (230.37% increase), and Changchuan Technology (138.39% increase) [1][2] Group 2: Industry Overview - The electronic industry is represented by Luxshare Precision and Changchuan Technology, both showing strong performance [2] - The machinery equipment sector includes Dalian Heavy Industry, which has also reported positive growth [2] - The basic chemical industry is represented by Wanhua Chemical and Brother Technology, both of which have shown substantial year-on-year profit increases [2]
江阴华新精密科技股份有限公司关于变更公司注册资本、公司类型及修订《公司章程》并办理工商变更登记的公告
Core Viewpoint - Jiangyin Huaxin Precision Technology Co., Ltd. has announced changes in its registered capital and company type following its successful public offering and listing on the Shanghai Stock Exchange, which will enhance its operational capabilities and corporate governance [1][2]. Group 1: Changes in Registered Capital and Company Type - The company has completed a public offering of 43.7375 million shares, increasing its registered capital from RMB 131,212,500 to RMB 174,950,000 [1]. - The company type has changed from "non-listed, natural person investment or control" to "listed, natural person investment or control" [2]. Group 2: Amendments to Company Articles - The company plans to revise its articles of association to reflect the changes in total share capital, registered capital, and company type, with the revised document to be disclosed on the Shanghai Stock Exchange [3]. Group 3: Authorization for Business Registration Changes - The board of directors has been authorized to handle the necessary business registration changes without needing further shareholder approval, as per previous resolutions from shareholder meetings [4]. Group 4: Fundraising and Financial Management - The company raised a total of RMB 813.5175 million through its public offering, with a net amount of RMB 727.1896 million after deducting issuance costs [15][23]. - The company intends to use part of the temporarily idle raised funds for cash management, with an investment limit of up to RMB 420 million in low-risk financial products [21][27]. Group 5: Use of Self-Funded Payments - The company will utilize self-funds and bank acceptance bills to pay for part of the project costs during the implementation phase, with plans to replace these with raised funds later [46][49].
华新精科:聘任何蓉蓉女士为证券事务代表
Zheng Quan Ri Bao· 2025-09-25 14:08
Group 1 - The company announced the appointment of He Rongrong as the securities affairs representative [2]
华新精科:关于使用自有资金、银行承兑汇票等方式支付募投项目部分款项并以募集资金等额置换的公告
Core Viewpoint - Huaxin Jingke announced the approval of a proposal to use self-owned funds and bank acceptance bills to pay for part of the fundraising project costs, with plans to replace these with raised funds later [1] Group 1 - The fourth meeting of the fourth board of directors was held on September 25, 2025 [1] - The company will use self-owned funds and bank acceptance bills as needed during the implementation of the fundraising project [1] - The funds used will be replaced with raised funds in equal amounts, which will be transferred from the fundraising special account to the company's general account [1]
华新精科:关于使用募集资金置换预先投入募投项目及已支付发行费用的自筹资金公告
Core Viewpoint - The company announced the approval of a proposal to use raised funds to replace self-raised funds that were previously invested in fundraising projects and to cover issuance costs [1] Group 1 - The fourth meeting of the fourth board of directors will be held on September 25, 2025 [1] - The proposal does not require submission to the shareholders' meeting as it falls within the board's approval authority [1]
华新精科(603370) - 华泰联合证券有限责任公司关于江阴华新精密科技股份有限公司使用自有资金、银行承兑汇票等方式支付募投项目部分款项并以募集资金等额置换的核查意见
2025-09-25 09:31
华泰联合证券有限责任公司关于 江阴华新精密科技股份有限公司使用自有资金、银行承兑汇票 等方式支付募投项目部分款项并以募集资金等额置换的核查意 见 华泰联合证券有限责任公司(以下简称"华泰联合证券"或"保荐机构") 作为江阴华新精密科技股份有限公司(以下简称"华新精科"或"公司")首次 公开发行股票并在主板上市的保荐机构,根据《证券发行上市保荐业务管理办法》 《上市公司募集资金监管规则》《上海证券交易所股票上市规则》《上海证券交 易所上市公司自律监管指引第1号——规范运作》等有关法律法规和规范性文件 的规定,对华新精科使用自有资金、银行承兑汇票等方式支付募投项目部分款项 并以募集资金等额置换事项进行了认真、审慎核查,具体核查情况如下: 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意江阴华新精密科技股份有限公司首 次公开发行股票注册的批复》(证监许可[2025]1394号),公司向社会公开发行 人民币普通股股票4,373.75万股,发行价格为18.60元/股,募集资金总额81,351.75 万元,扣除发行费用8,632.79万元(不含增值税)后,实际募集资金净额为 72,718.96万元(如有尾数差异 ...
华新精科(603370) - 华泰联合证券有限责任公司关于江阴华新精密科技股份有限公司使用部分暂时闲置募集资金进行现金管理的核查意见
2025-09-25 09:31
华泰联合证券有限责任公司 关于江阴华新精密科技股份有限公司 使用部分暂时闲置募集资金进行现金管理的 核查意见 华泰联合证券有限责任公司(以下简称"华泰联合"或"保荐机构")作为江 阴华新精密科技股份有限公司(以下简称"华新精科"或"公司")首次公开发行 股票的保荐机构,根据《证券发行上市保荐业务管理办法》《上海证券交易所股票 上市规则》等有关规定,对公司本次拟使用部分暂时闲置募集资金进行现金管理事 项进行了审慎核查,核查情况如下: 一、募集资金的基本情况 根据中国证券监督管理委员会《关于同意江阴华新精密科技股份有限公司首次 公开发行股票注册的批复》(证监许可[2025]1394号),公司向社会公开发行人民 币普通股股票4,373.75万股,发行价格为18.60元/股,募集资金总额81,351.75万元, 扣除发行费用8,632.79万元(不含增值税)后,实际募集资金净额为72,718.96万元 (如有尾数差异,为四舍五入所致),其中超募资金为1,520.63万元。募集资金已 全部到位,容诚会计师事务所(特殊普通合伙)对上述募集资金到位情况进行了审 验,并出具了《验资报告》(容诚验字[2025]510Z0005 ...
华新精科(603370) - 华泰联合证券有限责任公司关于江阴华新精密科技股份有限公司2025年持续督导培训情况报告
2025-09-25 09:31
华泰联合证券有限责任公司关于 江阴华新精密科技股份有限公司 2025 年度持续督导培训情况报告 上海证券交易所: 华泰联合证券有限责任公司(以下简称"华泰联合"或"保荐机构")作为 江阴华新精密科技股份有限公司(以下简称"华新精科"或"公司")首次公开 发行股票的保荐机构,根据《证券发行上市保荐业务管理办法》《上海证券交易 所股票上市规则》等有关规定以及华新精科的实际情况,对华新精科的董事、高 级管理人员等相关人员进行了 2025 年度持续督导培训,报告如下: 一、培训的主要内容 2025 年 9 月 22 日,保荐代表人蓝博靖、张帅对公司董事、高级管理人员等 相关人员进行了培训,并派发了相关培训资料,督促其认真学习培训内容。本次 培训重点介绍了持续督导的整体工作要求、内幕信息管理、实际控制人及董监高 其他行为规范、上市公司违规案例等相关内容,通过介绍相关法律法规规定及案 例分析等方式进行讲解,向公司介绍了资本市场内幕信息管理、常见违法违规行 为及对应的处罚案例,加深了董事和高级管理人员等相关人员在行为规范方面的 理解。 保荐代表人蓝博靖、张帅。 (此页无正文,为《华泰联合证券有限责任公司关于江阴华新精密科技 ...
华新精科(603370) - 华泰联合证券有限责任公司关于江阴华新精密科技股份有限公司使用募集资金置换预先已投入募投项目及已支付发行费用的自筹资金的核查意见
2025-09-25 09:31
华泰联合证券有限责任公司关于 江阴华新精密科技股份有限公司使用募集资金置换预先投 入募投项目及已支付发行费用的自筹资金的核查意见 募集资金到位前,公司通过自筹资金提前实施新能源车用驱动电机铁芯扩建 项目及精密冲压及模具研发中心项目。截至 2025 年 8 月 29 日,公司以自筹资金 预先投入募集资金投资项目的实际投资额为人民币 30,786.65 万元,公司拟使用 募集资金进行等额置换。具体情况如下表所示: 一、募集资金及投资项目基本情况 根据中国证券监督管理委员会《关于同意江阴华新精密科技股份有限公司首 次公开发行股票注册的批复》(证监许可[2025]1394 号),公司向社会公开发行 人民币普通股股票 4,373.75 万股,发行价格为 18.60 元/股,募集资金总额 81,351.75 万元,扣除发行费用 8,632.79 万元(不含增值税)后,实际募集资金 净额为 72,718.96 万元(如有尾数差异,为四舍五入所致),其中超募资金为 1,520.63 万元。募集资金已全部到位,容诚会计师事务所(特殊普通合伙)对上 述募集资金到位情况进行了审验,并出具了《验资报告》 (容诚验字 [2025]51 ...
华新精科(603370) - 江阴华新精密科技股份有限公司章程
2025-09-25 09:31
江阴华新精密科技股份有限公司 章 程 (2025 年修订) 二零二五年九月 | 第一章 | 总则 1 | | --- | --- | | 第二章 | 经营宗旨和范围 2 | | 第三章 | 股份 2 | | 第四章 | 股东和股东会 6 | | 第五章 | 董事会 26 | | 第六章 | 高级管理人员 43 | | 第七章 | 财务会计制度、利润分配和审计 44 | | 第八章 | 通知 50 | | 第九章 | 合并、分立、增资、减资、解散和清算 51 | | 第十章 | 修改章程 55 | | 第十一章 | 附则 56 | 江阴华新精密科技股份有限公司章程 第一章 总则 第一条 为维护江阴华新精密科技股份有限公司(以下简称"公司")、股东、 职工和债权人的合法权益,规范公司的组织和行为,根据《中华人民共和国公司 法》(以下简称"《公司法》")、《中华人民共和国证券法》(以下简称"《证 券法》")及其他相关法律、行政法规和规范性文件的规定,制订本章程。 第二条 公司系依照《公司法》和其他有关规定,由原有限责任公司整体变 更设立的股份有限公司,原有限公司的股东现为股份公司的发起人。公司在无锡 市行政审批局注 ...